De novo daptomycin nonsusceptibility in a clinical isolate [1]

Journal of Clinical Microbiology

Volumn 44, Issue 2, 2006, Pages 673-

  Lesho, Emil P ^a   Wortmann, Glenn W ^a   Craft, David ^a   Moran, Kimberly A ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; GENTAMICIN; LINEZOLID; PENICILLIN G; VANCOMYCIN;

AGED; ANTIBIOTIC RESISTANCE; BLOOD CULTURE; BONE MARROW SUPPRESSION; CASE REPORT; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; FEVER; HUMAN; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; WEAKNESS;

AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; DAPTOMYCIN; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; VANCOMYCIN RESISTANCE;

ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM;

EID: 32344434877     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.2.673.2006     Document Type: Letter

References (9)

1. Anonymous. Linezolid (Zyvox) package insert LAB 0139-10.0, revised May 2005. Pharmacia & Upjohn, Division of Pfizer Inc., New York, N.Y.
2. Edmond, M. B., J. F. Ober, D. L. Weinbaum, et al. 1995. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin. Infect. Dis. 20:1126-1133.
3. Mangili, A., I. Bica, D. R. Snydman, and D. H. Hamer. 2005. Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. Clin. Infect. Dis. 40:1058-1060.
4. Munoz-Price, L. S., K. Lolans, and J. P. Quinn. 2005. Emergence of resistance to daptomycin during treatment of vancomycin resistant Enterococcus faecalis infection. Clin. Infect. Dis. 41:565-566.
5. Sabol, K., J. E. Patterson, J. S. Lewis, A. Owens, J. Cadena, and J. H. Jorgensen. 2005. Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy. Antimicrob. Agents Chemother. 49:1664-1665.
6. Segreti, J. 11 May 2005, posting date. Efficacy of current agents used in the treatment of gram-positive infections and the consequences of resistance. Clin. Microbiol. Infect. (Suppl. 3):29-35. [Online.]
7. Silverman, J. A., N. Oliver, T. Andrew, and T. Li. 2001. Resistance studies with daptomycin. Antimicrob. Agents Chemother. 45:1799-1802.
8. Stevens, M. P., and M. B. Edmond. 2005. Endocarditis due to vancomycin-resistant enterococci: case report and review of the literature. Clin. Infect. Dis. 41:1134-1142.
9. Tonieporth, N. G., R. B. Roberts, J. Joylene, A. Hafner, and L. W. Riley. 1996. Risk factors associated with vancomycin-resistant Enterococcus faectum infection or colonization in 145 matched case patients and control patients. Clin. Infect. Dis. 23:767-772.